arrow
M

Michael P. Brown

Centre for Cancer Biology
H指数:60
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hemopurifier device in patients with solid tumours who have stable or progressive disease while on a treatment that includes pembrolizumab or nivolumab: protocol for an Australian safety, feasibility and dose-finding study

在正在接受包含帕博利珠单抗或纳武利尤单抗治疗、患有实体瘤且病情稳定或进展的患者中使用血液净化装置:一项澳大利亚安全性、可行性和剂量探索研究的方案

2026-01-050
OA
Growth rates of patient-derived tumor organoids reflect glioblastoma patients' heterogeneity in survival

患者来源的肿瘤类器官的生长速率反映了胶质母细胞瘤患者生存的异质性

2025-11-010
OAAI
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer
2023-09-203
OA
Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors
2023-01-1212
OAAI
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma

通过转基因IL-15表达增强的GD2-targeting car-t细胞是胶质母细胞瘤的有效且临床可行的治疗方法

2022-09-2753
OAAI